The Antinociceptive Effects of Nicotinic Partial Agonists Varenicline and Sazetidine-A in Murine Acute and Tonic Pain Models

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2012-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.112.194506PMID 22678099PMCID PMC3422531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.

  2012cited by this paper
• The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.

  2011cited by this paper
• Electrophysiological Perspectives on the Therapeutic Use of Nicotinic Acetylcholine Receptor Partial Agonists

  2011cited by this paper
• Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague–Dawley rats

  2011cited by this paper
• Pharmacological effects of nonselective and subtype‐selective nicotinic acetylcholine receptor agonists in animal models of persistent pain

  2010cited by this paper
• Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

  2010cited by this paper
• Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.

  2010cited by this paper
• Role of α5 Nicotinic Acetylcholine Receptors in Pharmacological and Behavioral Effects of Nicotine in Mice

  2010cited by this paper
• Nicotinic Partial Agonists Varenicline and Sazetidine-A Have Differential Effects on Affective Behavior

  2010cited by this paper
• Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.

  2009cited by this paper
• The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System

  2009cited by this paper
• Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.

  2009cited by this paper
• The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo.

  2008cited by this paper
• Analgesic Effects of Sazetidine-A, a New Nicotinic Cholinergic Drug

  2008cited by this paper
• Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant α4β2 Nicotinic Acetylcholine Receptors

  2008cited by this paper
• Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.

  2008cited by this paper
• Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.

  2007cited by this paper
• The α4β2α5 nicotinic cholinergic receptor in rat brain is resistant to up‐regulation by nicotine in vivo

  2007cited by this paper
• Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

  2007cited by this paper
• Genetic Approaches Identify Differential Roles for α4β2* Nicotinic Receptors in Acute Models of Antinociception in Mice

  2007cited by this paper
• Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

  2007cited by this paper
• Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.

  2007cited by this paper
• Sazetidine-A, A Novel Ligand That Desensitizes α4β2 Nicotinic Acetylcholine Receptors without Activating Them

  2006cited by this paper
• METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO

  2006cited by this paper
• Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.

  2006influential reference
• Heterogeneity of Nicotinic Cholinergic Receptors in Rat Superior Cervical and Nodose Ganglia

  2006cited by this paper
• Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.

  2006influential reference
• Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

  2006cited by this paper
• Cytisine for smoking cessation: a literature review and a meta-analysis.

  2006cited by this paper
• Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.

  2005cited by this paper
• Antinociceptive effects of the stereoisomers of nicotine given intrathecally in spinal rats

  2005cited by this paper
• Cigarette smoking, blood lipids, and baroreceptor-modulated nociception

  2005cited by this paper
• Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes

  2005cited by this paper
• The Dorsal Raphe Nucleus as a Site of Action of the Antinociceptive and Behavioral Effects of the α4 Nicotinic Receptor Agonist Epibatidine

  2005cited by this paper
• In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice

  2005cited by this paper
• Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat

  2005cited by this paper
• Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

  2005cited by this paper
• Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

  2004cited by this paper
• Nicotinic acetylcholine receptor distribution in relation to spinal neurotransmission pathways

  2003cited by this paper
• Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

  2002cited by this paper
• The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

  2001cited by this paper
• Nicotinic receptors at the amino acid level.

  2000cited by this paper
• Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception.

  1999cited by this paper
• Physiological evidence that the 'interphase' in the formalin test is due to active inhibition.

  1999cited by this paper
• Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

  1999cited by this paper
• Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.

  1998cited by this paper
• Role of the Nucleus Raphe Magnus in Antinociception Produced by ABT-594: Immediate Early Gene Responses Possibly Linked to Neuronal Nicotinic Acetylcholine Receptors on Serotonergic Neurons

  1998cited by this paper
• α-Conotoxin AuIB Selectively Blocks α3β4 Nicotinic Acetylcholine Receptors and Nicotine-Evoked Norepinephrine Release

  1998cited by this paper
• alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.

  1998cited by this paper
• Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.

  1998cited by this paper
• Optimal scoring strategies and weights for the formalin test in rats

  1997cited by this paper
• Epibatidine binding sites and activity in the spinal cord.

  1997cited by this paper
• Differential Regulation of Neuronal Nicotinic Receptor Binding Sites Following Chronic Nicotine Administration

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• The formalin test: scoring properties of the first and second phases of the pain response in rats

  1995cited by this paper
• Institute of Laboratory Animal Resources.

  1995cited by this paper
• Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans.

  1994cited by this paper
• Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats.

  1993cited by this paper
• The formalin test: an evaluation of the method

  1992cited by this paper
• Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus.

  1991cited by this paper
• Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.

  1989cited by this paper
• Autoradiographic distribution of [3H]acetylcholine binding sites in the cervical spinal cord of man and some other species.

  1988cited by this paper
• The spinal cord as a major site for the antinociceptive action of nicotine in the rat.

  1986cited by this paper
• Manual of pharmacologic calculations with computer programs

  1982cited by this paper
• Intrathecal morphine in mice: a new technique.

  1980cited by this paper
• The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests.

  1970cited by this paper
• The analgesic and sedative effects of nicotine in white mice, rabbits and golden hamsters.

  1968cited by this paper
• A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

  1941cited by this paper
• Analgesic effects of

  year unknowninfluential reference

• New Pharmacological Insight into Etanercept and Pregabalin in Allodynia and Nociception: Behavioral Studies in a Murine Neuropathic Pain Model

  2024cites this paper
• Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy

  2024cites this paper
• Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence

  2023cites this paper
• Desensitizing nicotinic agents normalize tinnitus-related inhibitory dysfunction in the auditory cortex and ameliorate behavioral evidence of tinnitus

  2023cites this paper
• Cigarette smoking, opioid consumption, and pain intensity after major surgery: An observational study

  2023influential citation
• Consensus statement on smoking cessation in patients with pain

  2022cites this paper
• Characterization of an α 4/7-Conotoxin LvIF from Conus lividus That Selectively Blocks α3β2 Nicotinic Acetylcholine Receptor

  2021cites this paper
• Central possible antinociceptive mechanism of naringin

  2021cites this paper
• The nAChR chaperone TMEM35a (NACHO) contributes to the development of hyperalgesia in mice.

  2021cites this paper
• Dynamics and Interactions of GPI-Linked Lynx1 Protein with/without Nicotinic Acetylcholine Receptor in Membrane Bilayers.

  2020cites this paper
• Pharmacological treatment of pain among persons with opioid addiction: A systematic review and meta‐analysis with implications for drug development

  2020cites this paper
• Behavioral Pharmacology of the Cholinergic System

  2020cites this paper
• Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors.

  2020cites this paper
• Countering Opioid-induced Respiratory Depression in Male Rats with Nicotinic Acetylcholine Receptor Partial Agonists Varenicline and ABT 594

  2020cites this paper
• Alteration in behavior of rat after chronic exposure to acetamiprid

  2019cites this paper
• Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation

  2019influential citation
• Targeting Nicotinic Acetylcholine Receptors for the Treatment of Pain

  2019cites this paper
• Augmenting the antinociceptive effects of nicotinic acetylcholine receptor activity through lynx1 modulation

  2018cites this paper
• Mechanistic bases for the adverse interaction of nicotine and chronic pain

  2018cites this paper
• Nicotine Deprivation Increases Pain Intensity, Neurogenic Inflammation, and Mechanical Hyperalgesia Among Daily Tobacco Smokers

  2018cites this paper
• Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN

  2018cites this paper
• Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury

  2018cites this paper
• Plasticity in Brainstem Mechanisms of Pain Modulation by Nicotinic Acetylcholine Receptors in the Rat

  2017cites this paper
• Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system.

  2016cites this paper
• Targeting glutamate homeostasis for potential treatment of nicotine dependence.

  2016cites this paper
• Clonidine complexation with hydroxypropyl-beta-cyclodextrin: From physico-chemical characterization to in vivo adjuvant effect in local anesthesia.

  2016cites this paper
• The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain.

  2015cites this paper
• The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors

  2015cites this paper
• Nicotinic receptors modulate the function of presynaptic AMPA receptors on glutamatergic nerve terminals in the trigeminal caudal nucleus.

  2015cites this paper
• Role of a 5-containing nicotinic receptors in neuropathic pain and response to nicotine

  2015cites this paper
• Effects of Nicotinic Acetylcholine Receptor Agonists in Assays of Acute Pain-Stimulated and Pain-Depressed Behaviors in Rats

  2015cites this paper
• Metformin Enhances Analgesia of Low-Dose Fluoxetine in Models of Acute and Persistent Pain in Mice: A Role of Astrocytic Activation

  2015cites this paper
• Nicotinic Receptors as Targets for Novel Analgesics and Anti-inflammatory Drugs

  2014cites this paper
• Sazetidine-A Activates and Desensitizes Native α7 Nicotinic Acetylcholine Receptors

  2014cites this paper
• Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2′-Fluoro-3′-(substituted pyridinyl)-7-deschloroepibatidine Analogues

  2014cites this paper
• Varenicline disrupts prepulse inhibition only in high-inhibitory rats.

  2014cites this paper
• Acute Activation, Desensitization and Smoldering Activation of Human Acetylcholine Receptors

  2013cites this paper
• Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective α4β2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats.

  2013cites this paper
• Nicotine is a pain reliever in trauma- and chemotherapy-induced neuropathy models.

  2013cites this paper
• Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptors.

  2012cites this paper